TY - JOUR
T1 - Acute encephalitis in the immunocompromised individual
AU - Saylor, Deanna
AU - Thakur, Kiran
AU - Venkatesan, Arun
N1 - Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015/8/25
Y1 - 2015/8/25
N2 - Purpose of review This article describes recent advances in the diagnosis and management of encephalitis in immunocompromised individuals. Recent findings Herpes simplex virus (HSV) and varicella zoster virus (VZV) are common causes of encephalitis in immunocompromised individuals, although clinical manifestations may be atypical, and thus challenging to recognize. Recently, an increased incidence of HSV and VZV central nervous system infections has been reported in association with novel immunosuppressive and immunomodulatory treatments. The free-living ameba Balamuthia mandrillaris causes granulomatous encephalitis predominantly in immunocompromised individuals and is associated with nearly uniform fatality. In the setting of organ transplantation, the recipient's immunocompromised state along with the potential for donor-transmitted infections can result in a unique epidemiology of encephalitis, including infection by human herpes virus-6 and BK virus. Recent studies utilizing next-generation sequencing techniques have identified several pathogens, including Leptospira santarosai and a neurotropic astrovirus, as causes of encephalitis in immunocompromised individuals. Summary Diagnosis and management of encephalitis is challenging in immunocompromised individuals, in part because of atypical clinical presentations and the presence of uncommon or novel infectious agents. Unbiased techniques for pathogen discovery are likely to play an increasing role in the diagnosis of central nervous system infections in immunocompromised individuals.
AB - Purpose of review This article describes recent advances in the diagnosis and management of encephalitis in immunocompromised individuals. Recent findings Herpes simplex virus (HSV) and varicella zoster virus (VZV) are common causes of encephalitis in immunocompromised individuals, although clinical manifestations may be atypical, and thus challenging to recognize. Recently, an increased incidence of HSV and VZV central nervous system infections has been reported in association with novel immunosuppressive and immunomodulatory treatments. The free-living ameba Balamuthia mandrillaris causes granulomatous encephalitis predominantly in immunocompromised individuals and is associated with nearly uniform fatality. In the setting of organ transplantation, the recipient's immunocompromised state along with the potential for donor-transmitted infections can result in a unique epidemiology of encephalitis, including infection by human herpes virus-6 and BK virus. Recent studies utilizing next-generation sequencing techniques have identified several pathogens, including Leptospira santarosai and a neurotropic astrovirus, as causes of encephalitis in immunocompromised individuals. Summary Diagnosis and management of encephalitis is challenging in immunocompromised individuals, in part because of atypical clinical presentations and the presence of uncommon or novel infectious agents. Unbiased techniques for pathogen discovery are likely to play an increasing role in the diagnosis of central nervous system infections in immunocompromised individuals.
KW - free-living ameba
KW - herpes virus
KW - next-generation sequencing
KW - varicella zoster virus
KW - viral encephalitis
UR - http://www.scopus.com/inward/record.url?scp=84937954135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937954135&partnerID=8YFLogxK
U2 - 10.1097/QCO.0000000000000175
DO - 10.1097/QCO.0000000000000175
M3 - Review article
C2 - 26098507
AN - SCOPUS:84937954135
SN - 0951-7375
VL - 28
SP - 330
EP - 336
JO - Current opinion in infectious diseases
JF - Current opinion in infectious diseases
IS - 4
ER -